SFG
SBIO icon

Summit Financial Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Summit Financial Group’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,700
Closed -$264K – 197
2022
Q4 		$264K Hold
8,700
– – 0.1% 163
2022
Q3 		$262K Hold
8,700
– – 0.11% 162
2022
Q2 		$241K Hold
8,700
– – 0.09% 177
2022
Q1 		$293K Sell
8,700
-1,550
-15% -$53.7K 0.1% 169
2021
Q4 		$433K Sell
10,250
-1,200
-10% -$53.5K 0.14% 137
2021
Q3 		$521K Hold
11,450
– – 0.19% 124
2021
Q2 		$560K Hold
11,450
– – 0.21% 113
2021
Q1 		$576K Buy
11,450
+900
+9% +$49.8K 0.24% 97
2020
Q4 		$540K Buy
10,550
+1,500
+17% +$71.4K 0.24% 94
2020
Q3 		$372K Buy
9,050
+750
+9% +$30.9K 0.18% 103
2020
Q2 		$347K Buy
+8,300
New +$327K 0.18% 103

Other funds holding SBIO

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Summit Financial Group's SBIO Position: Q1 2023 in Review

Summit Financial Group sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2023, closing a stake of 8,700 shares — an estimated $264K sold.

Summit Financial Group first reported a position in SBIO in Q2 2020 and held it in 11 quarters. The position peaked at $576K in Q1 2021. 39 funds tracked by Wall St. Rank hold SBIO as of Q1 2023.

  • Summit Financial Group reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2023 after selling out during the quarter.
  • Summit Financial Group sold 8,700 ALPS Medical Breakthroughs ETF shares in Q1 2023, an estimated $264K.
  • Summit Financial Group first reported a position in ALPS Medical Breakthroughs ETF in Q2 2020 and held it in 11 quarters.
  • Summit Financial Group's ALPS Medical Breakthroughs ETF position peaked at $576K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2023.

Based on Summit Financial Group's 13F filing for Q1 2023, filed 11 Apr 2023.